PRMT5 and colorectal cancer: Further studies show that silencing PRMT5 by shRNA or inhibition of PRMT5 by specific inhibitor GSK591 suppresses colorectal cancer cell growth and cell cycle progression, which is closely related to PRMT5 enzyme activity (Figures 2, 3).